<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK53700" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK53700/" /><meta name="ncbi_pagename" content="Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/12/29" /><meta name="citation_author" content="Stanislav Kmoch" /><meta name="citation_author" content="Martina Živná" /><meta name="citation_author" content="Anthony J Bleyer" /><meta name="citation_pmid" content="21473025" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK53700/" /><meta name="citation_keywords" content="ADTKD-REN" /><meta name="citation_keywords" content="Early-Onset Hyperuricemia, Anemia, and Progressive Tubulointerstitial Nephropathy" /><meta name="citation_keywords" content="Familial Juvenile Hyperuricemic Nephropathy Type 2" /><meta name="citation_keywords" content="FJHN2" /><meta name="citation_keywords" content="Familial Juvenile Hyperuricemic Nephropathy Type 2" /><meta name="citation_keywords" content="Early-Onset Hyperuricemia, Anemia, and Progressive Tubulointerstitial Nephropathy" /><meta name="citation_keywords" content="FJHN2" /><meta name="citation_keywords" content="ADTKD-REN" /><meta name="citation_keywords" content="Renin" /><meta name="citation_keywords" content="REN" /><meta name="citation_keywords" content="Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Stanislav Kmoch" /><meta name="DC.Contributor" content="Martina Živná" /><meta name="DC.Contributor" content="Anthony J Bleyer" /><meta name="DC.Date" content="2015/12/29" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK53700/" /><meta name="description" content="Autosomal dominant tubulointerstitial kidney disease, REN-related (ADTKD-REN) (previously familial juvenile hyperuricemic nephropathy type 2 [FJHN2]) is characterized by: hypoproliferative anemia with low hemoglobin concentrations, found in most affected children by age one year; hyperuricemia and gout, found in most (not all) affected individuals; and slowly progressive chronic tubulointerstitial kidney disease. Some affected children have polyuria (excessive urine production leading to frequent urination) and enuresis. Mildly elevated serum creatinine concentration and reduced estimated glomerular filtration rate in an asymptomatic child often progresses to end-stage renal disease in the fourth to sixth decades of life. Of note, information on only 14 families with this condition has been published; better understanding of the disease is likely to emerge when more families are described." /><meta name="og:title" content="Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant tubulointerstitial kidney disease, REN-related (ADTKD-REN) (previously familial juvenile hyperuricemic nephropathy type 2 [FJHN2]) is characterized by: hypoproliferative anemia with low hemoglobin concentrations, found in most affected children by age one year; hyperuricemia and gout, found in most (not all) affected individuals; and slowly progressive chronic tubulointerstitial kidney disease. Some affected children have polyuria (excessive urine production leading to frequent urination) and enuresis. Mildly elevated serum creatinine concentration and reduced estimated glomerular filtration rate in an asymptomatic child often progresses to end-stage renal disease in the fourth to sixth decades of life. Of note, information on only 14 families with this condition has been published; better understanding of the disease is likely to emerge when more families are described." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK53700/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/hyper-nfj2/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK53700/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D30E1E040EE6100000000017F0092.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK53700_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK53700_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mckd1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mckd2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK53700_"><span class="title" itemprop="name">Autosomal Dominant Tubulointerstitial Kidney Disease, <i>REN</i>-Related</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: ADTKD-<i>REN</i>; Early-Onset Hyperuricemia, Anemia, and Progressive Tubulointerstitial Nephropathy; Familial Juvenile Hyperuricemic Nephropathy Type 2; FJHN2</div><p class="contrib-group"><span itemprop="author">Stanislav Kmoch</span>, PhD, <span itemprop="author">Martina &#x0017d;ivn&#x000e1;</span>, PhD, and <span itemprop="author">Anthony J Bleyer</span>, MD, MS.</p><a data-jig="ncbitoggler" href="#__NBK53700_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK53700_ai__"><div class="contrib half_rhythm"><span itemprop="author">Stanislav Kmoch</span>, PhD<div class="affiliation small">Institute for Inherited Metabolic Disorders<br />Prague, Czech Republic<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="zc.inuc.1fl@hcomks" class="oemail">zc.inuc.1fl@hcomks</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Martina &#x0017d;ivn&#x000e1;</span>, PhD<div class="affiliation small">Institute for Inherited Metabolic Disorders<br />Prague, Czech Republic<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="zc.inuc.1fl@anvizm" class="oemail">zc.inuc.1fl@anvizm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anthony J Bleyer</span>, MD, MS<div class="affiliation small">Wake Forest University School of Medicine<br />Winston-Salem, North Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmbufw@reyelba" class="oemail">ude.cmbufw@reyelba</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 5, 2011</span>; Last Update: <span itemprop="dateModified">December 29, 2015</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="hyper-nfj2.Summary" itemprop="description"><h2 id="_hyper-nfj2_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant tubulointerstitial kidney disease, <i>REN</i>-related (ADTKD-<i>REN</i>) (previously <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> juvenile hyperuricemic nephropathy type 2 [FJHN2]) is characterized by: hypoproliferative anemia with low hemoglobin concentrations, found in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children by age one year; hyperuricemia and gout, found in most (not all) affected individuals; and slowly progressive chronic tubulointerstitial kidney disease. Some affected children have polyuria (excessive urine production leading to frequent urination) and enuresis. Mildly elevated serum creatinine concentration and reduced estimated glomerular filtration rate in an asymptomatic child often progresses to end-stage renal disease in the fourth to sixth decades of life. Of note, information on only 14 families with this condition has been published; better understanding of the disease is likely to emerge when more families are described.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnosis is based on findings of hypoproliferative anemia (low reticulocyte count relative to hemoglobin concentration and low erythropoietin concentration), hyperuricemia (serum uric acid concentration &#x0003e;6 mg/dL), decreased fractional excretion of urinary uric acid, bland urinary sediment, and low plasma renin activity. Kidney size is normal or small with no evidence of cyst formation. <i>REN</i> (encoding renin) is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is known to cause ADTKD-<i>REN</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Anemia may be reversed by erythropoietin; acute gout typically responds well to prednisone or colchicine. Treatment of low plasma renin activity / low plasma concentration of aldosterone may be indicated prior to the development of Stage III chronic kidney disease. If hyperkalemia is present, treatment with fludrocortisone or potassium restriction may be indicated. When end-stage kidney disease develops, kidney transplantation can be performed. ADTKD-<i>REN</i> does not recur in the transplanted kidney, which produces renin in a normal manner.</p><p><i>Prevention of primary manifestations:</i> Treatment of hyperuricemia with allopurinol can prevent development of gout.</p><p><i>Surveillance:</i> Measurement of hemoglobin concentration and serum concentration of uric acid and creatinine annually starting at the time of diagnosis.</p><p><i>Agents/circumstances to avoid:</i> Nonsteroidal anti-inflammatory medications, especially in persons who are dehydrated. Angiotensin-converting enzyme inhibitors could aggravate the underlying relative renin deficit. Volume depletion and dehydration as well as high meat and seafood intake could exacerbate gout. Patients should not be on the low sodium diet that is typically used in chronic kidney disease.</p><p><i>Evaluation of relatives at risk:</i> If the <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of at-risk relatives may be considered, particularly in: children because of their increased risk for anemia; adolescents because of their increased risk for gout, which can be prevented with appropriate treatment; and relatives considering kidney donation.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ADTKD-<i>REN</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Each child of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Once the pathogenic variant has been identified in an affected family member, prenatal testing for at-risk pregnancies is possible.</p></div></div><div id="hyper-nfj2.Diagnosis"><h2 id="_hyper-nfj2_Diagnosis_">Diagnosis</h2><div id="hyper-nfj2.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Autosomal dominant tubulointerstitial kidney disease, <i>REN</i>-related (ADTKD-<i>REN</i>) <b>should be suspected</b> in individuals with the following clinical findings:</p><ul><li class="half_rhythm"><div><b>Hypoproliferative anemia</b> with low hemoglobin concentrations, found in most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children by age one year as a result of low erythropoietin production</div><ul><li class="half_rhythm"><div>Hemoglobin concentrations can be low (usually 9-11 g/dL).</div></li><li class="half_rhythm"><div>Reticulocyte count is low relative to the hemoglobin concentration.</div></li><li class="half_rhythm"><div>Erythropoietin concentration is low.</div></li><li class="half_rhythm"><div>All other hematologic aspects are normal.</div></li></ul></li><li class="half_rhythm"><div><b>Hyperuricemia and gout,</b> found in most (not all) <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals as a result of decreased renal excretion of uric acid</div><ul><li class="half_rhythm"><div>Hyperuricemia (serum uric acid concentration &#x0003e;6 mg/dL) is present in 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals beginning in childhood.</div></li><li class="half_rhythm"><div>Usually, hyperuricemia in an individual with normal kidney function corresponds to a serum concentration of uric acid &#x0003e;1 SD of the normal value for age and sex (see <a class="figpopup" href="/books/NBK53700/table/hyper-nfj2.T.serum_uric_acid_concentrati/?report=objectonly" target="object" rid-figpopup="fighypernfj2Tserumuricacidconcentrati" rid-ob="figobhypernfj2Tserumuricacidconcentrati">Table 1</a>) [<a class="bk_pop" href="#hyper-nfj2.REF.wilcox.1996.731">Wilcox 1996</a>].</div></li><li class="half_rhythm"><div>Fractional excretion of urinary uric acid is decreased in the vast majority of individuals with ADTKD-<i>REN</i> (see <a class="figpopup" href="/books/NBK53700/table/hyper-nfj2.T.fractional_excretion_of_uri/?report=objectonly" target="object" rid-figpopup="fighypernfj2Tfractionalexcretionofuri" rid-ob="figobhypernfj2Tfractionalexcretionofuri">Table 2</a>).</div></li></ul></li><li class="half_rhythm"><div><b>Slowly progressive chronic tubulointerstitial kidney disease</b></div><ul><li class="half_rhythm"><div class="half_rhythm">Urinalysis reveals a bland urinary sediment (i.e., little blood or protein). Hematuria is generally not present, and excretion of protein is &#x0003c;1 g/24h except when kidney failure is advanced.</div></li><li class="half_rhythm"><div class="half_rhythm">Plasma renin is low.</div></li><li class="half_rhythm"><div class="half_rhythm">Plasma aldosterone is low.</div></li><li class="half_rhythm"><div class="half_rhythm">Serum potassium is mildly elevated.</div></li><li class="half_rhythm"><div class="half_rhythm">Renal ultrasound shows normal to small kidney size without cysts.</div></li><li class="half_rhythm"><div class="half_rhythm">Kidney biopsy (see Note):</div><div class="half_rhythm">Histologic examination reveals focal tubular atrophy, secondary glomerular scarring, and interstitial fibrosis [<a class="bk_pop" href="#hyper-nfj2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</a>].</div><div class="half_rhythm">Immunostaining for renin and prorenin is markedly decreased compared to control tissues in the granular cells of the juxtaglomerular apparatus and undetectable in the tubular epithelium early in the course of the disease. In advanced stages, neither the granular cells of the juxtaglomerular apparatus or the tubular epithelium stain for renin or prorenin.</div><div class="half_rhythm">Note: Kidney biopsy should NOT be performed to establish a diagnosis of ADTKD-<i>REN</i> because it is an invasive procedure with some risk and pathologic findings are too nonspecific to reliably identify the causative disorder. Molecular genetic testing (see <a href="#hyper-nfj2.Establishing_the_Diagnosis">Establishing the Diagnosis</a>), the gold standard for diagnosis, is safer and less expensive than kidney biopsy. However, some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals (or their relatives) may have undergone kidney biopsy prior to consideration of ADTKD-<i>REN</i> as a diagnostic possibility.</div></li></ul></li><li class="half_rhythm"><div><b>Autosomal dominant inheritance</b></div></li></ul><div id="hyper-nfj2.T.serum_uric_acid_concentrati" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Serum Uric Acid Concentration in Individuals with Normal Renal Function</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK53700/table/hyper-nfj2.T.serum_uric_acid_concentrati/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hyper-nfj2.T.serum_uric_acid_concentrati_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_1" style="text-align:left;vertical-align:middle;">Age</th><th id="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Serum Concentration (mg/dL)</th></tr><tr><th headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2" id="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Males</th><th headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2" id="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Females</th></tr></thead><tbody><tr><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5 years</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.6&#x000b1;0.9</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.6&#x000b1;0.9</td></tr><tr><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5-10 years</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.1&#x000b1;1.0</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.1&#x000b1;1.0</td></tr><tr><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12 years</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.4&#x000b1;1.1</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.5&#x000b1;0.9</td></tr><tr><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15 years</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.6&#x000b1;1.1</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.5&#x000b1;0.9</td></tr><tr><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;18 years</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6.2&#x000b1;0.8</td><td headers="hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_1_2 hd_h_hyper-nfj2.T.serum_uric_acid_concentrati_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.0&#x000b1;0.7</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#hyper-nfj2.REF.mikkelsen.1965.242">Mikkelsen et al [1965]</a>, <a class="bk_pop" href="#hyper-nfj2.REF.harkness.1969.773">Harkness &#x00026; Nicol [1969]</a>, <a class="bk_pop" href="#hyper-nfj2.REF.wilcox.1996.731">Wilcox [1996]</a></p></div></dd></dl></div></div></div><div id="hyper-nfj2.T.fractional_excretion_of_uri" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Fractional Excretion of Urinary Uric Acid in Individuals with Normal Renal Function</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK53700/table/hyper-nfj2.T.fractional_excretion_of_uri/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hyper-nfj2.T.fractional_excretion_of_uri_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:top;">Age</th><th id="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Mean</th><th id="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Standard Deviation&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">0-6 weeks</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">29.1%</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">11.7</td></tr><tr><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">6 weeks - 1 year</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">23.9%</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">10.4</td></tr><tr><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">1-3 years</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">15.2%</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">6.2</td></tr><tr><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" colspan="2" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">3-13 years</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">12.2%</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">5.5</td></tr><tr><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;13 years</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Female</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">8.0%</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3.7</td></tr><tr><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_1" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Male</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">10.3%</td><td headers="hd_h_hyper-nfj2.T.fractional_excretion_of_uri_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">4.2</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#hyper-nfj2.REF.stib_rkov_.2006.1301">Stib&#x0016f;rkov&#x000e1; et al [2006]</a></p></div></dd><dt></dt><dd><div><p class="no_margin">The fractional excretion of urinary uric acid can be calculated as follows:</p></div></dd><dt></dt><dd><div><p class="no_margin"><b>urine uric acid concentration x serum creatinine concentration &#x000f7;</b></p></div></dd><dt></dt><dd><div><p class="no_margin"><b>serum uric acid concentration x urine creatinine concentration</b></p></div></dd><dt>1. </dt><dd><div id="hyper-nfj2.TF.2.1"><p class="no_margin">A fractional excretion of urate &#x0003e;1 SD below the mean suggests reduced urate excretion.</p></div></dd></dl></div></div></div></div><div id="hyper-nfj2.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of ADTKD-<i>REN</i>
<b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>REN</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK53700/table/hyper-nfj2.T.molecular_genetic_testing_u/?report=objectonly" target="object" rid-figpopup="fighypernfj2Tmoleculargenetictestingu" rid-ob="figobhypernfj2Tmoleculargenetictestingu">Table 3</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>REN</i> is performed.</div><div class="half_rhythm">Note: Only pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and/or small insertions/deletions affecting renin biosynthesis and trafficking are expected to cause ADTKD-<i>REN</i>, therefore, <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing is not indicated.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>REN</i> and other genes of interest (see <a href="#hyper-nfj2.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>, and mitochondrial sequencing may be considered if single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>REN</i>) fails to confirm a diagnosis in an individual with features of ADTKD-<i>REN</i>. For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="hyper-nfj2.T.molecular_genetic_testing_u" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Autosomal Dominant Tubulointerstitial Kidney Disease, <i>REN</i>-Related</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK53700/table/hyper-nfj2.T.molecular_genetic_testing_u/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hyper-nfj2.T.molecular_genetic_testing_u_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hyper-nfj2.T.molecular_genetic_testing_u_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_hyper-nfj2.T.molecular_genetic_testing_u_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_hyper-nfj2.T.molecular_genetic_testing_u_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_hyper-nfj2.T.molecular_genetic_testing_u_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>REN</i></td><td headers="hd_h_hyper-nfj2.T.molecular_genetic_testing_u_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_hyper-nfj2.T.molecular_genetic_testing_u_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">14/14 families&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hyper-nfj2.TF.3.1"><p class="no_margin">See <a href="/books/NBK53700/#hyper-nfj2.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="hyper-nfj2.TF.3.2"><p class="no_margin">See <a href="#hyper-nfj2.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="hyper-nfj2.TF.3.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="hyper-nfj2.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#hyper-nfj2.REF.zivn_.2009.204">Zivn&#x000e1; et al [2009]</a>, <a class="bk_pop" href="#hyper-nfj2.REF.bleyer.2010a.366">Bleyer et al [2010a]</a>, <a class="bk_pop" href="#hyper-nfj2.REF.beck.2011.821">Beck et al [2011]</a></p></div></dd></dl></div></div></div></div></div><div id="hyper-nfj2.Clinical_Characteristics"><h2 id="_hyper-nfj2_Clinical_Characteristics_">Clinical Characteristics</h2><div id="hyper-nfj2.Clinical_Description"><h3>Clinical Description</h3><p>Fourteen families have been identified with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> tubulointerstitial kidney disease, <i>REN</i>-related (ADTKD-<i>REN</i>); therefore, the spectrum of clinical manifestations may not yet be fully appreciated.</p><p><b>First decade of life.</b> Children with ADTKD-<i>REN</i> may first be identified at age one year when a low hemoglobin concentration is identified during routine well child care. Although the children are asymptomatic, mild kidney failure may be evident on tests of renal function at that time.</p><p>Affected but as-yet undiagnosed children placed on a nonsteroidal anti-inflammatory drug during a febrile illness may develop acute kidney failure due to the combination of low plasma renin activity, volume depletion, and prostaglandin inhibition [<a class="bk_pop" href="#hyper-nfj2.REF.bleyer.2010a.366">Bleyer et al 2010a</a>]. Acute kidney failure usually resolves if treated appropriately, but chronic kidney failure and anemia may first be noted at that time.</p><p>Hyperuricemia with a low fractional excretion of uric acid is present in childhood but is usually asymptomatic.</p><p><b>Second decade of life.</b> As the child enters adolescence, the anemia resolves, and the hemoglobin concentration rises into the normal range.</p><p>Elevated uric acid concentrations may result in gout. Gout is associated with the acute onset of pain and erythema in the big toe, forefoot, heel, knee, or other joints. The diagnosis of gout is often missed in this condition because the gout may occur in children or young women, whereas traditional gout occurs in middle-aged men. Gout should be treated acutely with prednisone or colchicine. Gout can be prevented with long-term administration of allopurinol.</p><p>Some, but not all, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have:</p><ul><li class="half_rhythm"><div>Polyuria and excessive urine output due to decreased urinary concentrating ability [<a class="bk_pop" href="#hyper-nfj2.REF.bleyer.2010a.366">Bleyer et al 2010a</a>]. Polyuria present in childhood persists into adulthood.</div></li><li class="half_rhythm"><div>Mildly low blood pressure;</div></li><li class="half_rhythm"><div>Mildly elevated serum potassium concentration.</div></li></ul><p><b>Adulthood.</b> Renal function slowly worsens over time. A mildly elevated serum creatinine concentration and reduced estimated glomerular filtration rate in an asymptomatic child often progresses to end-stage renal disease (ESRD) in the fourth to sixth decades of life. Renal replacement therapy may be necessary in the fourth through seventh decades of life. Kidney transplantation cures the condition.</p></div><div id="hyper-nfj2.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are known at the present time.</p></div><div id="hyper-nfj2.Penetrance"><h3>Penetrance</h3><p>All <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have undergone genetic testing have been found to have anemia in childhood, hyperuricemia, and chronic kidney disease.</p><p>Chronic kidney disease occurs in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, although progression may be very slow, with ESRD occurring as late as the seventh decade in some individuals.</p></div><div id="hyper-nfj2.Nomenclature"><h3>Nomenclature</h3><p>According to the 2015 nomenclature [<a class="bk_pop" href="#hyper-nfj2.REF.eckardt.2015.676">Eckardt et al 2015</a>], the term "<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> tubulointerstitial kidney disease" (ADTKD) refers to the following disorders characterized by: (1) autosomal dominant inheritance; (2) slowly progressive chronic tubulointerstitial kidney disease resulting in ESRD in the third through seventh decade of life; (3) urinalysis revealing a bland urinary sediment (i.e., little blood or protein); and (4) renal ultrasound examination that is normal early in the disease course [<a class="bk_pop" href="#hyper-nfj2.REF.bleyer.2010a.366">Bleyer et al 2010a</a>]:</p><ul><li class="half_rhythm"><div>Autosomal dominant tubulointerstitial kidney disease &#x02013; <i>MUC1</i>-related (ADTKD-<i>MUC1</i>; previously known as <a href="/books/n/gene/mckd1/">medullary cystic kidney disease type 1</a>) [<a class="bk_pop" href="#hyper-nfj2.REF.kirby.2013.299">Kirby et al 2013</a>]</div></li><li class="half_rhythm"><div>Autosomal dominant tubulointerstitial kidney disease &#x02013; <i>UMOD</i>-related (ADTKD-<i>UMOD</i>; previously known as <a href="/books/n/gene/mckd2/"><i>UMOD</i>-associated kidney disease</a>, <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> juvenile hyperuricemic nephropathy type 1, medullary cystic kidney disease type 2 [MCKD2], or uromodulin storage disease)</div></li><li class="half_rhythm"><div>Autosomal dominant tubulointerstitial kidney disease &#x02013; <i>REN</i>-related (ADTKD-<i>REN</i>; previously known as <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> juvenile hyperuricemic nephropathy type 2 or <i>REN</i>-associated kidney disease) [<a class="bk_pop" href="#hyper-nfj2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</a>]</div></li></ul><p>Note: (1) The term "nephronophthisis/medullary cystic kidney disease (NPH/MCKD) complex" was used in the past to refer to both <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> forms of hereditary chronic tubulointerstitial disease [<a class="bk_pop" href="#hyper-nfj2.REF.hildebrandt.1992.802">Hildebrandt et al 1992</a>]. Nephronophthisis is now used to refer to a group of conditions with autosomal recessive inheritance that present in childhood with chronic kidney failure. These conditions are caused by pathogenic variants in at least 12 different genes, denoted as nephrocystins (<i>NPHP1</i>- <i>NPHP11</i>, <i>NPHP1L</i>) [<a class="bk_pop" href="#hyper-nfj2.REF.wolf.2011.181">Wolf &#x00026; Hildebrandt 2011</a>]. Clinical characteristics include polyuria, anemia, and slowly progressive kidney failure. See <a href="/books/n/gene/nephron-ov/">Nephronophthisis</a>. (2) Medullary sponge kidney (MSK), associated with calcifications of the medulla of the kidney, hypercalciuria, hematuria, and tubular acidification defects [<a class="bk_pop" href="#hyper-nfj2.REF.gambaro.2006.663">Gambaro et al 2006</a>], is not in any way related to medullary cystic kidney disease.</p></div><div id="hyper-nfj2.Prevalence"><h3>Prevalence</h3><p>Autosomal dominant tubulointerstitial kidney disease, <i>REN</i>-related (ADTKD-<i>REN</i>) is extremely rare, with only approximately 14 families having been identified worldwide. Several researchers who have studied inherited kidney disease in large numbers of families with inherited kidney disease have identified only a few families with this condition.</p></div></div><div id="hyper-nfj2.Genetically_Related_Allelic_D"><h2 id="_hyper-nfj2_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>REN.</i></p><p>Homozygosity or compound heterozygosity for <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> (<a class="def" href="/books/n/gene/glossary/def-item/null/">null</a>) <i>REN</i> variants results in grossly normal kidneys that show loss of proximal tubular differentiation. Autosomal recessive renal tubular dysgenesis is lethal in the perinatal period [<a class="bk_pop" href="#hyper-nfj2.REF.gribouval.2005.964">Gribouval et al 2005</a>].</p></div><div id="hyper-nfj2.Differential_Diagnosis"><h2 id="_hyper-nfj2_Differential_Diagnosis_">Differential Diagnosis</h2><p><a class="figpopup" href="/books/NBK53700/figure/hyper-nfj2.F1/?report=objectonly" target="object" rid-figpopup="fighypernfj2F1" rid-ob="figobhypernfj2F1">Figure 1</a> provides a flow diagram to aid in the differential diagnosis of inherited kidney disease.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="fighypernfj2F1" co-legend-rid="figlgndhypernfj2F1"><a href="/books/NBK53700/figure/hyper-nfj2.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="fighypernfj2F1" rid-ob="figobhypernfj2F1"><img class="small-thumb" src="/books/NBK53700/bin/hyper-nfj2-Image001.gif" src-large="/books/NBK53700/bin/hyper-nfj2-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndhypernfj2F1"><h4 id="hyper-nfj2.F1"><a href="/books/NBK53700/figure/hyper-nfj2.F1/?report=objectonly" target="object" rid-ob="figobhypernfj2F1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Testing strategy for inherited kidney disease &#x02013; updated 2015 </p></div></div><p><b>Hereditary glomerulonephritis.</b> Affected individuals usually have proteinuria and/or hematuria. If blood or protein is present in the urine, consider inherited glomerulonephritis (e.g., <a href="/books/n/gene/alport/">Alport syndrome</a>). Although rare individuals with <a href="/books/n/gene/mckd2/">ADTKD-<i>UMOD</i></a> have been found to have proteinuria, this is uncharacteristic.</p><p><a href="/books/n/gene/pkd-ad/"><b>Autosomal dominant polycystic kidney disease</b></a>
<b>(ADPKD).</b> If the urinary sediment is bland (i.e., with little blood or protein) in persons with kidney disease inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, one must exclude ADPKD, in which a large number of cysts are seen on renal ultrasound examination in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals older than age 25 years.</p><p><b>Other forms of ADTKD.</b> If the individual does not have ADPKD and the urinary sediment is bland, the two other forms of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> tubulointerstitial kidney disease to consider are the following:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/mckd1/">ADTKD-<i>MUC1</i></a> is associated with pathogenic variants in <i>MUC1</i>. Affected individuals have slowly progressive chronic kidney disease and minimal proteinuria. An important differentiating factor is that in ADTKD-<i>MUC1</i> gout usually only occurs in the setting of stage III or later chronic kidney disease. Affected individuals do not suffer from anemia or other manifestations in childhood.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/mckd2/">ADTKD<i>-UMOD</i></a>. Like ADTKD-<i>REN</i>, this condition is associated with slowly progressive chronic kidney disease. Persons with a <i>UMOD</i>-associated kidney disease do not have anemia in childhood and do not have the mild hyperkalemia often seen in ADTKD-<i>REN</i>.</div></li></ul><p><a href="/books/n/gene/nephron-ov/"><b>Nephronophthisis</b></a>
<b>(NPH)</b> is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of tubulointerstitial kidney disease. Like ADTKD-<i>REN</i>, it is often seen in childhood and can be associated with anemia and mild hypotension. The two conditions differ in three respects: (1) ADTKD-<i>REN</i> is usually associated with a family history of kidney disease, anemia, and gout. In nephronophthisis, a positive family history would not be expected because the disorder is inherited in an autosomal recessive manner. (2) Anemia in ADTKD-<i>REN</i> will be present from infancy, whereas anemia in nephronophthisis usually correlates with the level of kidney function. (3) The severity of kidney failure is usually much greater in nephronophthisis, with <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals usually requiring dialysis in their teens and early twenties. In contrast, individuals with ADTKD-<i>REN</i> usually have an eGFR &#x0003e;50 mL/min into early adulthood. NPH is associated with pathogenic variants in one of at least 19 known genes.</p><p><a href="/books/n/gene/fabry/"><b>Fabry disease</b></a><b>,</b> an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder, results from deficient activity of the enzyme &#x003b1;-galactosidase (&#x003b1;-Gal) A and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with &#x0003c;1% &#x003b1;-Gal A activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesias), the appearance of vascular cutaneous lesions (angiokeratomas), hypohidrosis, characteristic corneal and lenticular opacities, and proteinuria (usually exceeding that seen in <a href="/books/n/gene/mckd2/">ADTKD-<i>UMOD</i></a>). Gradual deterioration of renal function to end-stage renal disease (ESRD) usually occurs in the third to fifth decade. Males with &#x0003e;1% &#x003b1;-Gal A activity have a cardiac or renal variant <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Rarely, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females may have symptoms as severe as those observed in males with the classic phenotype.</p></div><div id="hyper-nfj2.Management"><h2 id="_hyper-nfj2_Management_">Management</h2><div id="hyper-nfj2.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs of an individual diagnosed with ADTKD-<i>REN</i>, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Hemoglobin concentration to document the level of anemia</div></li><li class="half_rhythm"><div>Serum uric acid concentration to identify persons at risk for gout</div></li><li class="half_rhythm"><div>A 24-hour urine collection to quantify urine output and determine if polyuria is present (although this can usually determined by history). Clinical questioning regarding enuresis (bed-wetting) or frequent thirst or urination will help establish a diagnosis of polyuria.</div></li><li class="half_rhythm"><div>A standard basic metabolic panel to determine if hyperkalemia is present</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="hyper-nfj2.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Anemia</b> may be reversed by treatment with erythropoietin [<a class="bk_pop" href="#hyper-nfj2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</a>], a medication that is given subcutaneously and managed by hematologists or pediatric nephrologists. Dose is based on response to therapy. There is no clear target at this time and it is left to the discretion of the hematologist or nephrologist. Many children have relatively mild anemia with hemoglobin levels of 10 to 11 g/dL, and can be safely followed off of erythropoietin.</p><p>Note: The dose of erythropoietin will need to be reduced as hemoglobin concentration increases during adolescence.</p><p><b>Hyperuricemia/gout.</b> Gout typically responds well to prednisone or colchicine. One should not use nonsteroidal agents in individuals with ADTKD-<i>REN</i> because the combination of nonsteroidal agents and the low renin state in patients with ADTKD-<i>REN</i> can lead to acute kidney injury; prednisone is the preferable alternative.</p><p>Prevention of future gout attacks with allopurinol or probenecid should be considered in individuals with gout. With allopurinol treatment, serum uric acid concentration returns to normal and gout attacks can be entirely prevented. Lifelong therapy with allopurinol may be required. In individuals with allergies or intolerance to allopurinol, febuxostat may be considered; however, no data on the use of this medication in <i>REN</i>-associated kidney disease are available.</p><p><b>Hypotension and mild hyperkalemia</b> may be present in children and young adults with this condition. As chronic kidney disease progresses to stage III chronic kidney disease, hypertension may develop, and hyperkalemia is due not to low plasma renin activity but rather to decreased elimination of potassium by the kidneys.</p><p>Therefore, treatment of low plasma renin activity / plasma concentration of aldosterone may be indicated prior to the development of stage III chronic kidney disease. Such treatment may include liberal sodium intake if the patient has mild hypotension and hyperkalemia but preserved kidney function. Dietary sodium intake of 3-4 g/day may prevent hypotension. Note: A low-sodium diet should not be used in persons with ADTKD-<i>REN</i>.</p><p>If hyperkalemia is present, treatment with fludrocortisone or potassium restriction may be indicated [<a class="bk_pop" href="#hyper-nfj2.REF.bleyer.2010b.411">Bleyer et al 2010b</a>]. Fludrocortisone treatment (0.1 mg orally/day) of one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child with low plasma renin activity resulted in a mild rise in blood pressure, correction of mild hyperkalemia, and a significant improvement in estimated glomerular filtration rate that may have been hemodynamically mediated [<a class="bk_pop" href="#hyper-nfj2.REF.bleyer.2010b.411">Bleyer at al 2010b</a>]. The use of fludrocortisone may also prevent hypotension that could result from volume depletion such as that associated with viral syndromes or vigorous activities associated with excessive perspiration. Note: Fludrocortisone treatment in two adults with advanced kidney disease had no clinical effect [Author, personal observation].</p><p>Fludrocortisone could have the advantage of decreasing renin production (through negative feedback), and thus the production of the abnormal renin deposits. However, since blockade of the renin angiotensin system and aldosterone production has been a general treatment of chronic kidney disease, it is possible that increased serum concentration of aldosterone may increase progression of renal disease. Thus, while the use of fludrocortisone may potentially be beneficial in this condition, at present its use is at the discretion of the clinician.</p><p><b>Mineralocorticoid replacement.</b> Recommendations regarding treatment are not evidence based due to the small number of individuals with this disorder and the limited experience treating <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Renal disease.</b> Referral to a nephrologist is indicated to monitor kidney function, evaluate for manifestations of chronic kidney disease, and prepare for renal replacement therapy when renal insufficiency occurs.</p><p>Renal replacement therapies such as hemodialysis and peritoneal dialysis replace renal function but are associated with potential complications.</p><p>Kidney transplantation cures ADTKD-<i>REN</i>. The transplanted kidney does not develop the disease.</p></div><div id="hyper-nfj2.Prevention_of_Primary_Manifes"><h3>Prevention of Primary Manifestations</h3><p>Treatment with erythropoietin can reverse anemia [<a class="bk_pop" href="#hyper-nfj2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</a>].</p><p>Treatment of hyperuricemia with allopurinol can prevent development of gout.</p></div><div id="hyper-nfj2.Prevention_of_Secondary_Compl"><h3>Prevention of Secondary Complications</h3><p>Iron stores should be replenished as needed to treat iron deficiency (an unrelated condition) if it is present.</p></div><div id="hyper-nfj2.Surveillance"><h3>Surveillance</h3><p>Measure hemoglobin concentration and serum concentration of uric acid and creatinine annually starting at the time of diagnosis.</p></div><div id="hyper-nfj2.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The use of nonsteroidal anti-inflammatory medications (NSAIDs) should be avoided, especially in persons who are dehydrated. The use of NSAIDs in a febrile child with ADTKD-<i>REN</i> precipitated acute renal failure [<a class="bk_pop" href="#hyper-nfj2.REF.bleyer.2010b.411">Bleyer et al 2010b</a>]. The use of other analgesics/antipyretics should be considered.</p><p>It would appear that the use of an angiotensin-converting enzyme inhibitor may not be beneficial in the treatment of chronic kidney failure and could aggravate the underlying relative renin deficit.</p><p>Volume depletion and dehydration may worsen hyperuricemia and lead to more frequent attacks of gout.</p><p>High meat and seafood intake could exacerbate gout.</p><p>Exertion under extreme conditions (e.g., physical exertion when it is hot) should be avoided.</p></div><div id="hyper-nfj2.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures. Particularly important are:</p><ul><li class="half_rhythm"><div>Children because of their increased risk for anemia;</div></li><li class="half_rhythm"><div>Adolescents because of their increased risk for gout, which can be prevented with allopurinol treatment;</div></li><li class="half_rhythm"><div>Relatives interested in donating a kidney to an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li></ul><p>See <a href="#hyper-nfj2.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="hyper-nfj2.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Successful pregnancies have been documented in women with a <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The rate of miscarriages or other adverse outcomes was not increased.</p></div><div id="hyper-nfj2.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="hyper-nfj2.Genetic_Counseling"><h2 id="_hyper-nfj2_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="hyper-nfj2.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Autosomal dominant tubulointerstitial kidney disease, <i>REN</i>-related (ADTKD-<i>REN</i>) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="hyper-nfj2.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with ADTKD-<i>REN</i> have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with ADTKD-<i>REN</i> may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Because <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if the pathogenic variant was <i>de novo</i>, the proportion of ADTKD-<i>REN</i> caused by <i>de novo</i> pathogenic variants is unknown.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the parents.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, two possible explanations are a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (although no instances of germline mosaicism have been reported, it remains a possibility).</div></li><li class="half_rhythm"><div>An apparently negative family history cannot be confirmed without <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div><ul><li class="half_rhythm"><div>Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of failure by health care professionals to recognize the disorder and/or a milder phenotypic presentation.</div></li><li class="half_rhythm"><div>Parents will usually have suffered from anemia in childhood, but they may not recall this from their childhood and/or the diagnosis of anemia may have been missed at that time.</div></li></ul></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has the <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with apparently unaffected parents are still at increased risk for ADTKD-<i>REN</i> (see <a href="#hyper-nfj2.Penetrance">Penetrance</a>).</div></li><li class="half_rhythm"><div>If the <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the empiric <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is approximately 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with ADTKD-<i>REN</i> has a 50% chance of inheriting the <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="hyper-nfj2.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#hyper-nfj2.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has ADTKD-<i>REN</i>, the <i>REN</i> pathogenic variant is likely <i>de novo</i>. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="hyper-nfj2.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for ADTKD-<i>REN</i> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="hyper-nfj2.Resources"><h2 id="_hyper-nfj2_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>REN-Related Kidney Disease Registry</b></div><div><i>Dr. Anthony Bleyer has established a registry of individuals with REN mutations. Please contact him (ableyer@wfubmc.edu) if interested in participation.</i></div><div><b>Email:</b> ableyer@wfubmc.edu</div></li></ul></div><div id="hyper-nfj2.Molecular_Genetics"><h2 id="_hyper-nfj2_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="hyper-nfj2.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK53700/table/hyper-nfj2.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hyper-nfj2.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_hyper-nfj2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_hyper-nfj2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_hyper-nfj2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_hyper-nfj2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_hyper-nfj2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_hyper-nfj2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_hyper-nfj2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5972" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>REN</i></a></td><td headers="hd_b_hyper-nfj2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5972" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q32<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hyper-nfj2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P00797" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Renin</a></td><td headers="hd_b_hyper-nfj2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/REN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">REN database</a></td><td headers="hd_b_hyper-nfj2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=REN" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">REN</a></td><td headers="hd_b_hyper-nfj2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=REN[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">REN</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="hyper-nfj2.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="hyper-nfj2.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related (<a href="/omim/179820,613092" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK53700/table/hyper-nfj2.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hyper-nfj2.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/179820" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">179820</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">RENIN; REN</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613092" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613092</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2</td></tr></tbody></table></div></div><div id="hyper-nfj2.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Renin is an aspartyl protease synthesized as preprorenin which contains a signal sequence that directs endoplasmic reticulum (ER) targeting, glycosylation, and proteolytic processing [<a class="bk_pop" href="#hyper-nfj2.REF.imai.1983.7405">Imai et al 1983</a>]. Renin cleaves angiotensinogen to angiotensin, with the subsequent stimulation of aldosterone production. The renin angiotesin system (RAS) has been found to have widespread and diverse roles, including modulating vascular tone, renal sodium and potassium handling, erythropoiesis, thirst, cardiac hypertrophy, and functioning through local RAS systems in many organs [<a class="bk_pop" href="#hyper-nfj2.REF.paul.2006.747">Paul et al 2006</a>].</p><p>In vitro studies have shown that the presence of the mutated signal peptide affects renin targeting and cotranslational <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> of preprorenin into the ER and, thus, proper biosynthesis and intracellular trafficking of prorenin. This results in ER stress, cytosolic accumulation of abnormal non-glycosylated preprorenin, accelerated autophagocytosis, and reduced growth rate. In vivo this gradually reduces viability of renin-producing juxtaglomerular cells, and results &#x02013; by as-yet undefined mechanism(s) &#x02013; in tubular atrophy, nephron loss, and chronic kidney failure, similar to that observed in mice with ablated juxtaglomerular cells [<a class="bk_pop" href="#hyper-nfj2.REF.pentz.2004.r474">Pentz et al 2004</a>].</p><p><i>REN</i> pathogenic variants also result in decreased renin production, a goal of therapy for many chronic kidney diseases. Thus, the disease becomes its own treatment.</p><p><b>Gene structure.</b>
<i>REN</i> is located on <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 1 (<a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> position chr1:204123944-204135465; according to <a href="http://genome.ucsc.edu/cgi-bin/hgGateway?hgsid=190618133&#x00026;clade=mammal&#x00026;org=Human&#x00026;db=hg19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GRCh37/hg19 [Feb 2009] assembly</a>). The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises ten exons, which are transcribed into a 1493 bp-long transcript encoding for 406 amino-acid preprorenin (reference sequence <a href="/nuccore/NM_000537.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000537.3</a>). See <a href="/books/NBK53700/#hyper-nfj2.molgen.TA">Table A</a> for a detailed summary of gene and protein information.</p><p><b>Benign variants.</b> Variants in the C-terminal part of the protein have not been associated with disease and are hypothesized to be benign [<a class="bk_pop" href="#hyper-nfj2.REF.villard.1994.30307">Villard et al 1994</a>; Bleyer &#x00026; Kmoch, unpublished data].</p><p><b>Pathogenic variants.</b> Only pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants and/or small insertions/deletions affecting renin biosynthesis and trafficking are expected to cause ADTKD-<i>REN</i>. Pathogenic variants in exons 1 and 2, the exons encoding the signal peptide and propeptide, are expected to account for most pathogenic variants that result in ADTKD-<i>REN</i>.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Renin is normally produced by modified juxtaglomerular cells of the afferent arterioles in the macula densa of the kidney. Renin cleaves the N-terminal ten amino acids of angiotensinogen to produce angiotensin I, which is further converted to angiotensin II by angiotensin-converting enzyme. Angiotensin II stimulates aldosterone production. Through a number of mechanisms, renin and angiotensin help to maintain normal blood pressure and to lower serum potassium concentrations into the normal range.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> ADTKD-<i>REN</i> is caused by <i>REN</i> pathogenic variants predominantly in the signal sequence of the protein renin, affecting targeting and cotranslational <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> of preprorenin into the ER. This leads to reduced expression of renin and other components of the renin angiotensin system in kidney biopsy specimens of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. It is likely that expression of the mutated proteins has a dominant toxic effect gradually reducing the viability of renin-expressing cells. This alters the intrarenal renin-angiotensin system and the functionality of the juxtaglomerular apparatus, resulting in nephron dropout and progressive kidney failure.</p></div></div><div id="hyper-nfj2.References"><h2 id="_hyper-nfj2_References_">References</h2><div id="hyper-nfj2.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.beck.2011.821">Beck BB, Trachtman H, Gitman M, Miller I, Sayer JA, Pannes A, Baasner A, Hildebrandt F, Wolf MT. Autosomal dominant mutation in the signal peptide of renin in a kindred with anemia, hyperuricemia, and CKD. <span><span class="ref-journal">Am J Kidney Dis. </span>2011;<span class="ref-vol">58</span>:821–5.</span> [<a href="/pmc/articles/PMC3366501/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3366501</span></a>] [<a href="/pubmed/21903317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21903317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.bleyer.2010a.366">Bleyer AJ, Hart PS, Kmoch S. Hereditary interstitial kidney disease. <span><span class="ref-journal">Semin Nephrol. </span>2010a;<span class="ref-vol">30</span>:366–73.</span> [<a href="/pmc/articles/PMC4264385/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4264385</span></a>] [<a href="/pubmed/20807609" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20807609</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.bleyer.2010b.411">Bleyer AJ, Zivn&#x000e1; M, Hulkov&#x000e1; H, Hodanov&#x000e1; K, Vyletal P, Sikora J, Zivny J, Sovov&#x000e1; J, Hart TC, Adams JN, Elleder M, Kapp K, Haws R, Cornell LD, Kmoch S, Hart PS. Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone. <span><span class="ref-journal">Clin Nephrol. </span>2010b;<span class="ref-vol">74</span>:411–22.</span> [<a href="/pmc/articles/PMC4264543/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4264543</span></a>] [<a href="/pubmed/21084044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21084044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.eckardt.2015.676">Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report. <span><span class="ref-journal">Kidney Int. </span>2015;<span class="ref-vol">88</span>:676–83.</span> [<a href="/pubmed/25738250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25738250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.gambaro.2006.663">Gambaro G, Feltrin GP, Lupo A, Bonfante L, D&#x02019;Angelo A, Antonello A. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930&#x02019;s. <span><span class="ref-journal">Kidney Int. </span>2006;<span class="ref-vol">69</span>:663–70.</span> [<a href="/pubmed/16395272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16395272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.gribouval.2005.964">Gribouval O, Gonzales M, Neuhaus T, Aziza J, Bieth E, Laurent N, Bouton JM, Feuillet F, Makni S, Ben Amar H, Laube G, Delezoide AL, Bouvier R, Dijoud F, Ollagnon-Roman E, Roume J, Joubert M, Antignac C, Gubler MC. Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:964–8.</span> [<a href="/pubmed/16116425" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16116425</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.harkness.1969.773">Harkness RA, Nicol AD. Plasma uric acid levels in children. <span><span class="ref-journal">Arch Dis Child. </span>1969;<span class="ref-vol">44</span>:773–8.</span> [<a href="/pmc/articles/PMC2020338/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2020338</span></a>] [<a href="/pubmed/5356987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5356987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.hildebrandt.1992.802">Hildebrandt F, Waldherr R, Kutt R, Brandis M. The nephronophthisis complex: clinical and genetic aspects. <span><span class="ref-journal">Clin Investig. </span>1992;<span class="ref-vol">70</span>:802–8.</span> [<a href="/pubmed/1450635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1450635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.imai.1983.7405">Imai T, Miyazaki H, Hirose S, Hori H, Hayashi T, Kageyama R, Ohkubo H, Nakanishi S, Murakami K. Cloning and sequence analysis of cDNA for human renin precursor. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1983;<span class="ref-vol">80</span>:7405–9.</span> [<a href="/pmc/articles/PMC389959/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC389959</span></a>] [<a href="/pubmed/6324167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6324167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.kirby.2013.299">Kirby A, Gnirke A, Jaffe DB, Bare&#x00161;ov&#x000e1; V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, H&#x0016f;lkov&#x000e1; H, Sovov&#x000e1; J, Vylet'al P, Antignac C, Guttman M, Handsaker RE, Perrin D, Steelman S, Sigurdsson S, Scheinman SJ, Sougnez C, Cibulskis K, Parkin M, Green T, Rossin E, Zody MC, Xavier RJ, Pollak MR, Alper SL, Lindblad-Toh K, Gabriel S, Hart PS, Regev A, Nusbaum C, Kmoch S, Bleyer AJ, Lander ES, Daly MJ. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:299–303.</span> [<a href="/pmc/articles/PMC3901305/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3901305</span></a>] [<a href="/pubmed/23396133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23396133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.mikkelsen.1965.242">Mikkelsen WM, Dodge HJ, Valkenburg H. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan 1959-1960. <span><span class="ref-journal">Am J Med. </span>1965;<span class="ref-vol">39</span>:242–51.</span> [<a href="/pubmed/14320691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14320691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.paul.2006.747">Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. <span><span class="ref-journal">Physiol Rev. </span>2006;<span class="ref-vol">86</span>:747–803.</span> [<a href="/pubmed/16816138" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16816138</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.pentz.2004.r474">Pentz ES, Moyano MA, Thornhill BA, Sequeira Lopez ML, Gomez RA. Ablation of renin-expressing juxtaglomerular cells results in a distinct kidney phenotype. <span><span class="ref-journal">Am J Physiol Regul Integr Comp Physiol. </span>2004;<span class="ref-vol">286</span>:R474–83.</span> [<a href="/pubmed/14563659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14563659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.stib_rkov_.2006.1301">Stib&#x0016f;rkov&#x000e1; B, Posp&#x000ed;silov&#x000e1; E, Kmoch S, Sebesta I. Analysis of excretion fraction of uric acid. <span><span class="ref-journal">Nucleosides Nucleotides Nucleic Acids. </span>2006;<span class="ref-vol">25</span>:1301–4.</span> [<a href="/pubmed/17065111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17065111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.villard.1994.30307">Villard E, Lalau JD, van Hooft IS, Derkx FH, Houot AM, Pinet F, Corvol P, Soubrier F. A mutant renin gene in familial elevation of prorenin. <span><span class="ref-journal">J Biol Chem. </span>1994;<span class="ref-vol">269</span>:30307–12.</span> [<a href="/pubmed/7982942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7982942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.wilcox.1996.731">Wilcox WD. Abnormal serum uric acid levels in children. <span><span class="ref-journal">J Pediatr. </span>1996;<span class="ref-vol">128</span>:731–41.</span> [<a href="/pubmed/8648529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8648529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.wolf.2011.181">Wolf MT, Hildebrandt F. Nephronophthisis. <span><span class="ref-journal">Pediatr Nephrol. </span>2011;<span class="ref-vol">26</span>:181–94.</span> [<a href="/pmc/articles/PMC4160028/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4160028</span></a>] [<a href="/pubmed/20652329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20652329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hyper-nfj2.REF.zivn_.2009.204">Zivn&#x000e1; M, H&#x0016f;lkov&#x000e1; H, Matignon M, Hodanov&#x000e1; K, Vylet'al P, Kalb&#x000e1;cov&#x000e1; M, Baresov&#x000e1; V, Sikora J, Blazkov&#x000e1; H, Zivn&#x000fd; J, Iv&#x000e1;nek R, Str&#x000e1;neck&#x000fd; V, Sovov&#x000e1; J, Claes K, Lerut E, Fryns JP, Hart PS, Hart TC, Adams JN, Pawtowski A, Clemessy M, Gasc JM, G&#x000fc;bler MC, Antignac C, Elleder M, Kapp K, Grimbert P, Bleyer AJ, Kmoch S. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:204–13.</span> [<a href="/pmc/articles/PMC2725269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2725269</span></a>] [<a href="/pubmed/19664745" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19664745</span></a>]</div></li></ul></div></div><div id="hyper-nfj2.Chapter_Notes"><h2 id="_hyper-nfj2_Chapter_Notes_">Chapter Notes</h2><div id="hyper-nfj2.Author_Notes"><h3>Author Notes</h3><p>Dr Stanislav Kmoch (<a href="mailto:dev@null" data-email="zc.inuc.1fl@hcomks" class="oemail">zc.inuc.1fl@hcomks</a>) and Dr Anthony Bleyer (<a href="mailto:dev@null" data-email="ude.cmbufw@reyelba" class="oemail">ude.cmbufw@reyelba</a>) are actively involved in clinical research concerning individuals with renin pathogenic variants and other forms of inherited kidney disease; they would be happy to communicate with individuals who have any questions regarding diagnosis or other considerations.</p><p>Related website: <a href="http://www.wakehealth.edu/Nephrology/Gout-Kidney-Disease.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.wakehealth.edu/Nephrology/Gout-Kidney-Disease.htm</a></p></div><div id="hyper-nfj2.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>29 December 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 April 2011 (me) Review posted live</div></li><li class="half_rhythm"><div>21 December 2010 (ab) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK53700</span><span class="label">PMID: <a href="/pubmed/21473025" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">21473025</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mckd1/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mckd2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK53700&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK53700/?report=reader">PubReader</a></li><li><a href="/books/NBK53700/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK53700" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK53700" style="display:none" title="Cite this Page"><div class="bk_tt">Kmoch S, Živná M, Bleyer AJ. Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related. 2011 Apr 5 [Updated 2015 Dec 29]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK53700/pdf/Bookshelf_NBK53700.pdf">PDF version of this page</a> (585K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#hyper-nfj2.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#hyper-nfj2.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#hyper-nfj2.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#hyper-nfj2.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#hyper-nfj2.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#hyper-nfj2.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#hyper-nfj2.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#hyper-nfj2.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#hyper-nfj2.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#hyper-nfj2.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#hyper-nfj2.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5972[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">REN</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=2447206" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=2447206" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=2447206" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=2447206" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301530" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease<i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">, UMOD</i>-Related</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease<i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">, UMOD</i>-Related<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bleyer AJ, Hart PS, Kmoch S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23946964" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease, <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MUC1</i>-Related</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease, <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MUC1</i>-Related<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bleyer AJ, Kmoch S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29784615" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.</a><span class="source">[Am J Kidney Dis. 2018]</span><div class="brieflinkpop offscreen_noflow">Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ayasreh N, Bullich G, Miquel R, Furlano M, Ruiz P, Lorente L, Valero O, García-González MA, Arhda N, Garin I, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Kidney Dis. 2018 Sep; 72(3):411-418. Epub 2018 May 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28284384" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease.</a><span class="source">[Adv Chronic Kidney Dis. 2017]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bleyer AJ, Kidd K, Živná M, Kmoch S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Adv Chronic Kidney Dis. 2017 Mar; 24(2):86-93. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29569962" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.</a><span class="source">[Ren Fail. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lin Z, Yang J, Liu H, Cai D, An Z, Yu Y, Chen T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ren Fail. 2018 Nov; 40(1):146-151. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21473025" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21473025" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04127239a66ee2bab6d629">Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:52:51-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D30E1E040EE6100000000017F0092&amp;ncbi_session=CE8D30E1E0412721_0383SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK53700%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK53700&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK53700/&amp;ncbi_pagename=Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D30E1E0412721_0383SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>